ATC L: Antineoplastic & Immunomodulating Agents

150 multi-target drugs | Page 1 / 5

InChIKey Drug Name DrugBank ID Groups Targets Clinical
WINHZLLDWRZWRT... Sunitinib DB01268 approved investigational 201 Yes
XZXHXSATPCNXJR... Nintedanib DB09079 approved investigational 165 Yes
BMGQWWVMWDBQGC... Midostaurin DB06595 approved investigational 147 Yes
UBPYILGKFZZVDX... Bosutinib DB06616 approved investigational 130 Yes
KTEIFNKAUNYNJU... Crizotinib DB08865 approved investigational 114 No
ZBNZXTGUTAYRHI... Dasatinib DB01254 approved investigational 102 Yes
MLDQJTXFUGDVEO... Sorafenib DB00398 approved investigational 85 Yes
AILRADAXUVEEIR... Brigatinib DB12267 approved investigational 75 No
UHTHHESEBZOYNR... Vandetanib DB05294 approved 66 Yes
CUIHSIWYWATEQL... Pazopanib DB06589 approved investigational 61 Yes
PHXJVRSECIGDHY... Ponatinib DB08901 approved investigational 59 No
HHZIURLSWUIHRB... Nilotinib DB04868 approved investigational 57 Yes
JWNPDZNEKVCWMY... Neratinib DB11828 approved investigational 57 Yes
XXJWYDDUDKYVKI... Cediranib DB04849 investigational 52 No
AAKJLRGGTJKAMG... Erlotinib DB00530 approved investigational 50 Yes
GXJABQQUPOEUTA... Bortezomib DB00188 approved investigational 47 No
HAYYBYPASCDWEQ... Entrectinib DB11986 approved investigational 47 No
UZWDCWONPYILKI... Abemaciclib DB12001 approved investigational 47 No
RITAVMQDGBJQJZ... Axitinib DB06626 approved investigational 43 No
BLMPQMFVWMYDKT... Carfilzomib DB08889 approved investigational 43 No
XGALLCVXEZPNRQ... Gefitinib DB00317 approved investigational 39 Yes
KTUFNOKKBVMGRW... Imatinib DB00619 approved investigational 38 Yes
NKANXQFJJICGDU... Tamoxifen DB00675 approved investigational 35 Yes
CVWXJKQAOSCOAB... Quizartinib DB12874 approved investigational 35 No
XYFPWWZEPKGCCK... Ibrutinib DB09053 approved investigational 34 No
BFSMGDJOXZAERB... Dabrafenib DB08912 approved investigational 33 No
SPMVMDHWKHCIDT... Tivozanib DB11800 approved investigational 30 No
FNHKPVJBJVTLMP... Regorafenib DB08896 approved investigational 29 No
AHJRHEGDXFFMBM... Palbociclib DB09073 approved investigational 28 No
HWXVIOGONBBTBY... Pacritinib DB11697 approved investigational 27 No